Concepedia

Devalingam Mahalingam

DM

71

Publications

4.5K

Citations

37

H-Index

2009

Active since

Affiliations

The University of Texas Health Science Center at San Antonio(Current)

Northwestern University

Sarah Cannon

Cleveland Clinic

Oncolytics Biotech (Canada)

Devalingam Mahalingam is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, radiation oncology, and oncology.

ORCID

Top concepts

Publications per year

2009–2024

71

Publications

71

Combined autophagy and HDAC inhibition

Devalingam Mahalingam, Monica Mita, John Sarantopoulos et al. · Autophagy · 2014 · 281 citations · Full text

, , +18

Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia

Ronan Swords, Kevin R. Kelly, Peter G. Smith et al. · Blood · 2010 · 276 citations · Full text

Single‐cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT‐related genes in metastatic prostate cancer

Chun‐Liang Chen, Devalingam Mahalingam, Rohit R. Jadhav et al. · The Prostate · 2012 · 231 citations · Full text

A Phase I, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib (LDE225) in Patients with Advanced Solid Tumors

Jordi Rodón, Hussein Tawbi, Anne Thomas et al. · Clinical Cancer Research · 2014 · 228 citations · Full text

Autophagy inhibition enhances vorinostat‐induced apoptosis <i>via</i> ubiquitinated protein accumulation

Jennifer S. Carew, Ernest Medina, Juan Esquivel et al. · Journal of Cellular and Molecular Medicine · 2009 · 221 citations · Full text

Rows per page

1–5 of 71